Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 56

1.
2.

Mesenchymal stem cells protect podocytes from apoptosis induced by high glucose via secretion of epithelial growth factor.

Li D, Wang N, Zhang L, Hanyu Z, Xueyuan B, Fu B, Shaoyuan C, Zhang W, Xuefeng S, Li R, Chen X.

Stem Cell Res Ther. 2013;4(5):103.

3.

Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.

Wang S, Li Y, Zhao J, Zhang J, Huang Y.

Biol Blood Marrow Transplant. 2013 Apr;19(4):538-46. doi: 10.1016/j.bbmt.2013.01.001. Epub 2013 Jan 4.

4.

NFAT2 mediates high glucose-induced glomerular podocyte apoptosis through increased Bax expression.

Li R, Zhang L, Shi W, Zhang B, Liang X, Liu S, Wang W.

Exp Cell Res. 2013 Apr 15;319(7):992-1000. doi: 10.1016/j.yexcr.2013.01.007. Epub 2013 Jan 20.

PMID:
23340267
5.

Wnt/β-catenin signalling pathway mediates high glucose induced cell injury through activation of TRPC6 in podocytes.

Li Z, Xu J, Xu P, Liu S, Yang Z.

Cell Prolif. 2013 Feb;46(1):76-85. doi: 10.1111/cpr.12010.

PMID:
23294354
6.

Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.

Drapeau N, Lizotte F, Denhez B, Guay A, Kennedy CR, Geraldes P.

Am J Physiol Endocrinol Metab. 2013 Jun 1;304(11):E1188-98. doi: 10.1152/ajpendo.00560.2012. Epub 2013 Mar 26.

7.
8.

Gremlin aggravates hyperglycemia-induced podocyte injury by a TGFβ/smad dependent signaling pathway.

Li G, Li Y, Liu S, Shi Y, Chi Y, Liu G, Shan T.

J Cell Biochem. 2013 Sep;114(9):2101-13. doi: 10.1002/jcb.24559.

PMID:
23553804
9.

NFAT2 inhibitor ameliorates diabetic nephropathy and podocyte injury in db/db mice.

Zhang L, Li R, Shi W, Liang X, Liu S, Ye Z, Yu C, Chen Y, Zhang B, Wang W, Lai Y, Ma J, Li Z, Tan X.

Br J Pharmacol. 2013 Sep;170(2):426-39. doi: 10.1111/bph.12292.

10.

Carnosine prevents apoptosis of glomerular cells and podocyte loss in STZ diabetic rats.

Riedl E, Pfister F, Braunagel M, Brinkkötter P, Sternik P, Deinzer M, Bakker SJ, Henning RH, van den Born J, Krämer BK, Navis G, Hammes HP, Yard B, Koeppel H.

Cell Physiol Biochem. 2011;28(2):279-88. doi: 10.1159/000331740. Epub 2011 Aug 16.

11.

Impact of high glucose and transforming growth factor-β on bioenergetic profiles in podocytes.

Stieger N, Worthmann K, Teng B, Engeli S, Das AM, Haller H, Schiffer M.

Metabolism. 2012 Aug;61(8):1073-86. doi: 10.1016/j.metabol.2011.12.003. Epub 2012 Feb 24.

PMID:
22365040
12.

Spironolactone inhibits hyperglycemia-induced podocyte injury by attenuating ROS production.

Toyonaga J, Tsuruya K, Ikeda H, Noguchi H, Yotsueda H, Fujisaki K, Hirakawa M, Taniguchi M, Masutani K, Iida M.

Nephrol Dial Transplant. 2011 Aug;26(8):2475-84. doi: 10.1093/ndt/gfq750. Epub 2011 Jan 10.

PMID:
21220752
13.

mTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice.

Inoki K, Mori H, Wang J, Suzuki T, Hong S, Yoshida S, Blattner SM, Ikenoue T, Rüegg MA, Hall MN, Kwiatkowski DJ, Rastaldi MP, Huber TB, Kretzler M, Holzman LB, Wiggins RC, Guan KL.

J Clin Invest. 2011 Jun;121(6):2181-96. doi: 10.1172/JCI44771. Epub 2011 May 23.

14.

Activation of a local renin angiotensin system in podocytes by glucose.

Durvasula RV, Shankland SJ.

Am J Physiol Renal Physiol. 2008 Apr;294(4):F830-9. doi: 10.1152/ajprenal.00266.2007. Epub 2008 Jan 23.

15.

Mesenchymal stem cell therapy promotes renal repair by limiting glomerular podocyte and progenitor cell dysfunction in adriamycin-induced nephropathy.

Zoja C, Garcia PB, Rota C, Conti S, Gagliardini E, Corna D, Zanchi C, Bigini P, Benigni A, Remuzzi G, Morigi M.

Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1370-81. doi: 10.1152/ajprenal.00057.2012. Epub 2012 Sep 5.

16.

BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury.

Mitu GM, Wang S, Hirschberg R.

Am J Physiol Renal Physiol. 2007 Nov;293(5):F1641-8. Epub 2007 Sep 5.

17.

Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.

Fang L, Radovits T, Szabó G, Mózes MM, Rosivall L, Kökény G.

Nephrol Dial Transplant. 2013 Jul;28(7):1751-61. doi: 10.1093/ndt/gfs391. Epub 2012 Nov 29.

PMID:
23203993
18.

Podocyte COX-2 exacerbates diabetic nephropathy by increasing podocyte (pro)renin receptor expression.

Cheng H, Fan X, Moeckel GW, Harris RC.

J Am Soc Nephrol. 2011 Jul;22(7):1240-51. doi: 10.1681/ASN.2010111149.

19.

Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats.

Hoshi S, Shu Y, Yoshida F, Inagaki T, Sonoda J, Watanabe T, Nomoto K, Nagata M.

Lab Invest. 2002 Jan;82(1):25-35.

PMID:
11796823
20.

Mechanical stretch and prostaglandin E2 modulate critical signaling pathways in mouse podocytes.

Faour WH, Thibodeau JF, Kennedy CR.

Cell Signal. 2010 Aug;22(8):1222-30. doi: 10.1016/j.cellsig.2010.03.014. Epub 2010 Mar 31.

PMID:
20362052

Supplemental Content

Support Center